Insider · CIK 0001856587

Ambrose Kristen

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001856587

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-28	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+5,000 sh	—	—	11,624
2026-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−357 sh	$483.36	−$173K	6,624
2026-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−223 sh	$486.35	−$108K	6,981
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−546 sh	$485.11	−$265K	7,204
2026-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−638 sh	$473.68	−$302K	7,750
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−1,557 sh	$489.46	−$762K	8,388
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−598 sh	$483.75	−$289K	9,945
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+1,809 sh	—	—	10,543
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−1,393 sh	$487.76	−$679K	8,734
2026-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−1,376 sh	$460.43	−$634K	10,127
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−592 sh	$468.41	−$277K	11,503
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+1,300 sh	—	—	12,095
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,950 sh	—	—	10,795
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−1,241 sh	$479.61	−$595K	7,845
2025-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−884 sh	$480.95	−$425K	9,086
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−828 sh	$483.28	−$400K	9,970
2025-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−671 sh	$455.06	−$305K	10,798
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−564 sh	$463.46	−$261K	11,469
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,080 sh	—	—	12,033
2025-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−1,376 sh	$459.83	−$633K	9,953
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−591 sh	$467.98	−$277K	11,329
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+1,854 sh	—	—	11,920
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,566 sh	—	—	10,066
2024-04-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−240 sh	$419.00	−$101K	7,500
2024-04-01	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−225 sh	$418.10	−$94.1K	7,740
2024-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−883 sh	$425.70	−$376K	7,965
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−828 sh	$431.79	−$358K	8,848
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−1,374 sh	$420.24	−$577K	9,676
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−591 sh	$422.74	−$250K	11,050
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+1,853 sh	—	—	11,641
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,950 sh	—	—	9,788
2023-05-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−289 sh	$329.82	−$95.3K	6,838
2023-03-31	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−176 sh	$313.74	−$55.2K	7,127
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−42 sh	$289.63	−$12.2K	7,303
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−183 sh	$288.68	−$52.8K	7,345
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−982 sh	$287.25	−$282K	7,528
2023-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−502 sh	$289.12	−$145K	8,510
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,566 sh	—	—	6,062
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,950 sh	—	—	9,012
2022-04-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−60 sh	$267.37	−$16K	3,763
2022-04-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−104 sh	$271.68	−$28.3K	3,496
2022-04-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−83 sh	$269.51	−$22.4K	3,600
2022-04-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	SVP & Chief Accounting Officer	SSale	−80 sh	$268.46	−$21.5K	3,683
2022-04-01	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	SVP & Chief Accounting Officer	FTax Payment	−137 sh	$263.09	−$36K	3,823
2022-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	SVP & Chief Accounting Officer	AAward	+2,566 sh	—	—	3,960

Recent filings

Accepted (ET)
Sep 14
Ambrose Kristen0000875320-26-000267
SEC(opens sec.gov)
Mar 24
Ambrose Kristen0000875320-26-000125
SEC(opens sec.gov)
Feb 264
Ambrose Kristen0000875320-26-000104
SEC(opens sec.gov)
Feb 194
Ambrose Kristen0000875320-26-000080
SEC(opens sec.gov)
Feb 184
Ambrose Kristen0000875320-26-000058
SEC(opens sec.gov)
Feb 124
Ambrose Kristen0000875320-26-000036
SEC(opens sec.gov)
Jan 264
Ambrose Kristen0001856587-26-000002
SEC(opens sec.gov)
Feb 284
Ambrose Kristen0000875320-25-000122
SEC(opens sec.gov)
Feb 264
Ambrose Kristen0000875320-25-000103
SEC(opens sec.gov)
Feb 194
Ambrose Kristen0000875320-25-000079
SEC(opens sec.gov)
Feb 144
Ambrose Kristen0000875320-25-000057
SEC(opens sec.gov)
Feb 124
Ambrose Kristen0000875320-25-000033
SEC(opens sec.gov)

Companies

VERTEX PHARMACEUTICALS INC / MASVP & Chief Accounting OfficerVRTX

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210